BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,946,000 | -12.8% | 55,793 | +1.1% | 0.03% | 0.0% |
| Q2 2020 | $3,380,000 | -0.2% | 55,173 | -7.9% | 0.03% | +3.3% |
| Q1 2020 | $3,387,000 | -4.8% | 59,885 | -4.2% | 0.03% | +42.9% |
| Q4 2019 | $3,559,000 | +8.2% | 62,516 | +1.7% | 0.02% | +10.5% |
| Q3 2019 | $3,289,000 | -35.0% | 61,461 | -27.5% | 0.02% | -26.9% |
| Q2 2019 | $5,061,000 | -1.7% | 84,762 | +2.6% | 0.03% | -3.7% |
| Q1 2019 | $5,151,000 | -1.9% | 82,648 | -4.6% | 0.03% | -6.9% |
| Q4 2018 | $5,250,000 | +3.8% | 86,626 | +0.2% | 0.03% | +20.8% |
| Q3 2018 | $5,056,000 | +38.4% | 86,435 | +6.1% | 0.02% | +41.2% |
| Q2 2018 | $3,654,000 | +50.0% | 81,464 | +48.3% | 0.02% | +54.5% |
| Q1 2018 | $2,436,000 | +185.2% | 54,939 | +178.7% | 0.01% | +175.0% |
| Q4 2017 | $854,000 | +67.8% | 19,716 | +80.0% | 0.00% | +100.0% |
| Q3 2017 | $509,000 | +1.6% | 10,951 | +8.2% | 0.00% | 0.0% |
| Q2 2017 | $501,000 | – | 10,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | 2,300 | $203,550,000 | 0.00% |